PTX 100: orphan drug designation PTX 200: 4 patients have...

PTX 100: orphan drug designation
PTX 200: 4 patients have achieved complete remission
CELL THERAPY: Stated by SYC that its been sought after by international drug companies
OMNICAR: Car-T therapy 2.0 licenced from the pioneers of CAR T therapies

as stated by SYC ptx only needs 1 drug to make it a multi billiondollar successful company but with the results that the company is producing i wouldnt be surprised we will have multiple drugs going into commercialisation.

the healthcare sectore has been one of the best performers last couple of weeks. signalling the sector has bottomed out and showing so many upside to investment, also sector is a known performer in high inflation environment.

oil price and commodity prices have all sold of indicating inflation has already peaked and next inflation reading wil show this, it will flow significant amonunt of money sitting on the sidelines back into equities

PTX is so undervalued at the moment trading in an oversold sector which puts it in a sweet spot for a good run all the best of luck PTXers next week gonna be a big week get them while you can.